Radiomics-based signature of breast cancer on preoperative contrast-enhanced MRI to predict axillary metastasis

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1. Leao D, Pereira ER, Perez-Marfil MN et al. The importance of spirituality for women facing breast cancer diagnosis: a qualitative study. Int. J. Environ. Res. Public Health 18(12), (2021).
  Google Scholar
• 2. Li R, Zhu L, Peng Y, Zhang X, Dai C, Liu D. TRIM50 suppresses pancreatic cancer progression and reverses the epithelial-mesenchymal transition via facilitating the ubiquitous degradation of snail1. Front. Oncol. 11, 695740 (2021).
  Medline CASGoogle Scholar
• 3. Dengel LT, Van Zee KJ, King TA et al. Axillary dissection can be avoided in the majority of clinically node-negative patients undergoing breast-conserving therapy. Ann. Surg. Oncol. 21(1), 22–27 (2014).
  MedlineGoogle Scholar
• 4. Yi M, Giordano SH, Meric-Bernstam F et al. Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs. SLNB with axillary lymph node dissection for node-positive breast cancer patients: experience from the SEER database. Ann. Surg. Oncol. 17(Suppl. 3), 343–351 (2010).
  MedlineGoogle Scholar
• 5. Zhang Y, Asad S, Weber Z et al. Genomic features of rapid versus late relapse in triple negative breast cancer. BMC Cancer 21(1), 568 (2021).
  Medline CASGoogle Scholar
• 6. Pesek S, Ashikaga T, Krag LE, Krag D. The false-negative rate of sentinel node biopsy in patients with breast cancer: a meta-analysis. World J. Surg. 36(9), 2239–2251 (2012).
  MedlineGoogle Scholar
• 7. Langer I, Guller U, Berclaz G et al. Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients. Ann. Surg. 245(3), 452–461 (2007).
  MedlineGoogle Scholar
• 8. Manca G, Tardelli E, Rubello D et al. Sentinel lymph node biopsy in breast cancer: a technical and clinical appraisal. Nucl. Med. Commun. 37(6), 570–576 (2016).
  MedlineGoogle Scholar
• 9. Sinha S, Malmi-Kakkada AN, Li X, Samanta HS, Thirumalai D. Spatially heterogeneous dynamics of cells in a growing tumor spheroid: comparison between theory and experiments. Soft Matter 16(22), 5294–5304 (2020).
  Medline CASGoogle Scholar
• 10. Vuong D, Tanadini-Lang S, Wu Z et al. Radiomics feature activation maps as a new tool for signature interpretability. Front. Oncol. 10, 578895 (2020).
  MedlineGoogle Scholar
• 11. Le Y, Kroeker R, Kipfer HD, Lin C. Development and evaluation of TWIST Dixon for dynamic contrast-enhanced (DCE) MRI with improved acquisition efficiency and fat suppression. J. Magn. Reson. Imaging 36(2), 483–491 (2012).
  MedlineGoogle Scholar
• 12. Luciani A, Pigneur F, Ghozali F et al. Ex vivo MRI of axillary lymph nodes in breast cancer. Eur. J. Radiol. 69(1), 59–66 (2009).
  MedlineGoogle Scholar
• 13. Yu Y, Tan Y, Xie C et al. Development and validation of a preoperative magnetic resonance imaging radiomics-based signature to predict axillary lymph node metastasis and disease-free survival in patients with early-stage breast cancer. JAMA Netw. Open 3(12), e2028086 (2020). •• Unlike previous studies focusing exclusively on the tumor region or axillary lymph node (ALN) region for predicting ALN metastasis, in this study, the ALN-tumor radiomic signature combining multisequence key radiomic features of ALN and tumor regions showed a high predictive ability and could be applied to predict the ALN status precisely.
  MedlineGoogle Scholar
• 14. Zhan C, Hu Y, Wang X, Liu H, Xia L, Ai T. Prediction of axillary lymph node metastasis in breast cancer using intra-peritumoral textural transition analysis based on dynamic contrast-enhanced magnetic resonance imaging. Acad. Radiol. 29(Suppl. 1), S107–S115 (2021). •• In this research, radiomics analysis with Ipris features can accurately predict ALN status based on dynamic contrast-enhanced MRI. The model, combining intratumoural and Ipris features, achieved a higher prediction performance in the independent testing dataset. It may be useful for precision medicine and could facilitate improved treatment strategies for patients with breast cancer.
  MedlineGoogle Scholar
• 15. Luo HB, Liu YY, Wang CH et al. Radiomic features of axillary lymph nodes based on pharmacokinetic modeling DCE-MRI allow preoperative diagnosis of their metastatic status in breast cancer. PLOS ONE 16(3), e0247074 (2021). • Based on the preliminary results of this study, it may be inferred that the ALN metastasis of breast cancer are more heterogeneous than the negative nodes. Radiomic methods can be used to decode the heterogeneity of axillary lymph nodes. Our findings provide impetus for further radiomic research to develop a non-invasive tool for diagnosis of metastatic lymph node and individualized treatment.
  Medline CASGoogle Scholar
• 16. Mao N, Dai Y, Lin F et al. Radiomics nomogram of DCE-MRI for the prediction of axillary lymph node metastasis in breast cancer. Front. Oncol. 10, 541849 (2020).
  MedlineGoogle Scholar
• 17. Leithner D, Mayerhoefer ME, Martinez DF et al. Non-invasive assessment of breast cancer molecular subtypes with multiparametric magnetic resonance imaging radiomics. J. Clin. Med. 9(6), (2020).
  MedlineGoogle Scholar
• 18. Agner SC, Rosen MA, Englander S et al. Computerized image analysis for identifying triple-negative breast cancers and differentiating them from other molecular subtypes of breast cancer on dynamic contrast-enhanced MR images: a feasibility study. Radiology 272(1), 91–99 (2014).
  MedlineGoogle Scholar
• 19. Allison KH, Hammond MEH, Dowsett M et al. Estrogen and progesterone receptor testing in breast cancer: ASCO/CAP guideline update. J. Clin. Oncol. 38(12), 1346–1366 (2020). • A worldwide guideline aiming to update key recommendations of the American Society of Clinical Oncology/College of American Pathologists estrogen and progesterone receptor testing in breast cancer guideline.
  MedlineGoogle Scholar
• 20. Port RE, Knopp MV, Brix G. Dynamic contrast-enhanced MRI using Gd-DTPA: interindividual variability of the arterial input function and consequences for the assessment of kinetics in tumors. Magn. Reson. Med. 45(6), 1030–1038 (2001).
  Medline CASGoogle Scholar
• 21. Klosowski J, Frahm J. Image denoising for real-time MRI. Magn. Reson. Med. 77(3), 1340–1352 (2017).
  MedlineGoogle Scholar
• 22. Chen Z, Zhou Z, Adnan S. Joint low-rank prior and difference of Gaussian filter for magnetic resonance image denoising. Med. Biol. Eng. Comput. 59(3), 607–620 (2021).
  Medline CASGoogle Scholar
• 23. Zhang L, Fried DV, Fave XJ, Hunter LA, Yang J, Court LE. IBEX: an open infrastructure software platform to facilitate collaborative work in radiomics. Med. Phys. 42(3), 1341–1353 (2015).
  MedlineGoogle Scholar
• 24. Parmar C, Grossmann P, Bussink J, Lambin P, Aerts H. Machine learning methods for quantitative radiomic biomarkers. Sci. Rep. 5, 13087 (2015).
  Medline CASGoogle Scholar
• 25. Julesz B. Experiments in the visual perception of texture. Sci. Am. 232(4), 34–43 (1975).
  Medline CASGoogle Scholar
• 26. Alksas A, Shehata M, Saleh GA et al. A novel computer-aided diagnostic system for accurate detection and grading of liver tumors. Sci. Rep. 11(1), 13148 (2021). • Radiogenomics and novel imaging developments are designed to understand hepatocellular carcinoma heterogeneity through imaging, and to facilitate individualized care for each tumor's unique signature. Advanced algorithms and trends approved their ability to enable greater precision in diagnosis and grading, along with potential guidance on personalized healthcare.
  Medline CASGoogle Scholar
• 27. Peters AA, Buchanan G, Ricciardelli C et al. Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancer. Cancer Res. 69(15), 6131–6140 (2009).
  Medline CASGoogle Scholar
• 28. Witten DM, Tibshirani R. Covariance-regularized regression and classification for high-dimensional problems. JR Stat. Soc. Series B Stat. Methodol. 71(3), 615–636 (2009).
  MedlineGoogle Scholar
• 29. Hotta M, Minamimoto R, Miwa K. 11C-methionine-PET for differentiating recurrent brain tumor from radiation necrosis: radiomics approach with random forest classifier. Sci. Rep. 9(1), 15666 (2019).
  MedlineGoogle Scholar
• 30. Chen S, Zhou S, Yin FF, Marks LB, Das SK. Investigation of the support vector machine algorithm to predict lung radiation-induced pneumonitis. Med. Phys. 34(10), 3808–3814 (2007).
  MedlineGoogle Scholar
• 31. Oba MS, Imoto S, Toh U et al. Observational study of axilla treatment for breast cancer patients with 1–3 positive micrometastases or macrometastases in sentinel lymph nodes. Jpn J. Clin. Oncol. 44(9), 876–879 (2014).
  MedlineGoogle Scholar
• 32. Cykowska A, Marano L, D'Ignazio A et al. New technologies in breast cancer sentinel lymph node biopsy; from the current gold standard to artificial intelligence. Surg. Oncol. 34, 324–335 (2020).
  MedlineGoogle Scholar
• 33. Chen HL, Zhou JQ, Chen Q, Deng YC. Comparison of the sensitivity of mammography, ultrasound, magnetic resonance imaging and combinations of these imaging modalities for the detection of small (≤2 cm) breast cancer. Medicine (Baltimore) 100(26), e26531 (2021).
  Medline CASGoogle Scholar
• 34. Liu J, Sun D, Chen L et al. Radiomics analysis of dynamic contrast-enhanced magnetic resonance imaging for the prediction of sentinel lymph node metastasis in breast cancer. Front. Oncol. 9, 980 (2019).
  MedlineGoogle Scholar
• 35. Guo X, Liu Z, Sun C et al. Deep learning radiomics of ultrasonography: identifying the risk of axillary non-sentinel lymph node involvement in primary breast cancer. EBioMedicine 60, 103018 (2020).
  MedlineGoogle Scholar
• 36. Msuya CA, Hartveit F. Skip lesions in the axilla in breast cancer, and their association with micrometastases. Breast Cancer Res. Treat. 19(3), 277–281 (1991).
  Medline CASGoogle Scholar
• 37. Samiei S, Granzier RWY, Ibrahim A et al. Dedicated axillary MRi-based radiomics analysis for the prediction of axillary lymph node metastasis in breast cancer. Cancers (Basel) 13(4), (2021). •• This study aimed to investigate the potential of dedicated axillary MRI-based radiomics analysis for the prediction of ALN metastases. Dedicated axillary MRI examinations provide a very specific and complete field of view of the axilla. Accurate preoperative prediction of ALN metastases in breast cancer patients using radiomics analysis can aid in clinical decision-making for the type of treatment.
  Google Scholar
• 38. Yu Y, He Z, Ouyang J et al. Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: a machine learning, multicenter study. EBioMedicine 69, 103460 (2021).
  Medline CASGoogle Scholar
• 39. Gates A, Vandermeer B, Hartling L. Technology-assisted risk of bias assessment in systematic reviews: a prospective cross-sectional evaluation of the RobotReviewer machine learning tool. J. Clin. Epidemiol. 96, 54–62 (2018).
  MedlineGoogle Scholar
• 40. Chetan MR, Gleeson FV. Radiomics in predicting treatment response in non-small-cell lung cancer: current status, challenges and future perspectives. Eur. Radiol. 31(2), 1049–1058 (2021).
  MedlineGoogle Scholar
• 41. Polverari G, Ceci F, Bertaglia V et al. (18)F-FDG Pet parameters and radiomics features analysis in advanced Nsclc treated with immunotherapy as predictors of therapy response and survival. Cancers (Basel) 12(5), (2020).
  MedlineGoogle Scholar
• 42. Xu A, Chu X, Zhang S et al. Prediction breast molecular typing of invasive ductal carcinoma based on dynamic contrast enhancement magnetic resonance imaging radiomics characteristics: a feasibility study. Front. Oncol. 12, 799232 (2022).
  Medline CASGoogle Scholar
• 43. Chamming's F, Ueno Y, Ferre R et al. Features from computerized texture analysis of breast cancers at pretreatment MR imaging are associated with response to neoadjuvant chemotherapy. Radiology 286(2), 412–420 (2018).
  MedlineGoogle Scholar
• 44. Joo L, Jung SC, Lee H et al. Stability of MRI radiomic features according to various imaging parameters in fast scanned T2-FLAIR for acute ischemic stroke patients. Sci. Rep. 11(1), 17143 (2021).
  Medline CASGoogle Scholar
• 45. Majidpoor J, Mortezaee K. Angiogenesis as a hallmark of solid tumors – clinical perspectives. Cell Oncol. (Dordr.) 44(4), 715–737 (2021).
  Medline CASGoogle Scholar